FDA Inspection 1300008 — Creative Testing Solutions

Creative Testing Solutions — FEI 1071905

The FDA completed an inspection of Creative Testing Solutions on January 14, 2026 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 14, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Memphis, TN (United States)